This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The startup’s AI platform, which was cleared by the FDA last year, automates ultrasound reporting so that healthcareproviders can conduct these exams with greater accuracy and efficiency. Samsung announced its plans to acquire French medtech startup Sonio.
travelers and healthcareproviders looking for another—and potentially safer—dengue vaccine will have to keep waiting. | U.S. travelers and healthcareproviders looking for another—and potentially safer—dengue vaccine will have to keep waiting.
The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digital health guidances and reports today and yesterday, providing some long-awaited clarity and peeks into the agency’s future plans. . The push started yesterday with the 31-page key findings report from the FDA Pre-Certification Program pilot.
Bringing the very first prescription digital therapeutic (PDT) to market in 2017, Pear Therapeutics went above and beyond to follow suggested regulatory guidelines, obtained Food & Drug Administration (FDA) clearance, and provided solid clinical study evidence.
The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. The precision therapy has been designed for potently and selectively inhibiting KIT D816V, which is the main underlying driver of the disease.
IN SUMMARY: American healthcare is failing. Not only has the FDA become a political pawn but almost half the population is now obese. While there are lots of reasons for this the silence of healthcareproviders is a huge reason.
Healthcareproviders make more money treating poor health than preventing it. The FDA could require all pharma product websites to add general health prevention information and links to credible online health information. The explanation of why is actually quite simple. Aye, that’s the question!
Understanding Your Audience: Different audiencespatients, healthcare professionals, or payersrequire tailored messages. For instance, while patients prioritize benefits and side effects, healthcareproviders look for clinical evidence and efficacy. What are the FDA requirements for direct-to-consumer ads?
Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.
The US Food and Drug Administration (FDA) is presently reviewing teplizumab for the delay of clinical T1D in people who are at risk. Simultaneously, the companies have signed a securities purchase agreement under which Sanofi will procure $35m of Provention’s common stock on teplizumab, obtaining FDA approval. .
Regulatory Restrictions on Keyword Use Pharmaceutical ads must comply with regulations from organizations like the FDA (U.S.) , MHRA (UK) , and EMA (EU). Generic drug manufacturers, healthcareproviders, and wellness brands often bid on similar terms. Understanding Pharma-Specific PPC Challenges 1.
BodyTom 64 is designed and manufactured to comply with the FDA Quality System Regulations and ISO 13485:2016 requirements and is in conformance with global regulatory harmonized standards. the healthcare subsidiary of Samsung Electronics Co., the healthcare subsidiary of Samsung Electronics Co., About NeuroLogica.
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcareproviders. Virtual health consultations, mobile apps, and online portals have made it easier to engage patients and healthcareproviders alike. Patient-Centric Marketing Patients want to feel heard.
Food and Drug Administration (FDA) for the Quantra Hemostasis System with QStat Cartridge. The FDA clearance of the QStat Cartridge expands the Quantra System’s indications for use to include trauma, and liver transplantation procedures. HemoSonics’ manufacturing, R&D, and Headquarters are based out of Durham, NC.
In the pharmaceutical industry, these networks often include healthcareproviders, patient groups, digital channels, and key opinion leaders (KOLs). It connected healthcareproviders, patients, and the general public through a cohesive network of trust.
Medical device apps can be used for a wide array of healthcare functions, such as: Tracking patient metrics (e.g., Businesses like Infuse Med know the need of following laws such FDA, HIPAA, and GDPR so that their apps not only operate well but also satisfy the necessary legal criteria for medical device safety and data protection.
There isn’t one method to get people exercising; it will take an approach for every healthcareprovider to communicate the importance of exercise. Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise.
The US Food and Drug Administration (FDA) has approved WINREVAIR ( sotatercept -csrk) for subcutaneous injection (45mg, 60mg) for adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1). Further findings from the Phase III trial The FDA approval is based on results from the Phase III STELLAR trial.
The US Food and Drug Administration (FDA) has granted approval to Amgen and AstraZeneca ’s Tezspire (tezepelumab-ekko) for self-administration using a single-use, pre-filled pen for severe asthma patients aged 12 years and above. Asthma control improvement and safety profile were consistent with previous clinical trials.
Are you targeting healthcareproviders (HCPs), patients, or payers? Follow FDA guidelines on advertising to ensure your messaging is accurate and ethical. Follow FDA guidelines, ensure accurate messaging, and work closely with legal and regulatory teams to review campaigns. Disclaimer: This content is not medical advice.
In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7
Whether you are marketing a new medical product or creating animations for instructional reasons, you must satisfy regulatory criteria established by the FDA, EMA, or another health authority. Our repertoire includes patient education, surgical demonstrations, and pharmaceutical animation among other facets of healthcare.
Axial3D, a leader in medical segmentation and 3D solutions, today announced that it is the first to receive FDA clearance for an automated, AI-driven, cloud-based segmentation platform for orthopedic trauma, orthopedic, maxillofacial, and cardiovascular applications. Are you hiring?
Stanza was made available to patients in September under the FDA’s Digital Health Enforcement Policy for Digital Health Devices, set up to facilitate access to remote therapies during the pandemic. It is available on prescription from healthcareproviders. It is due to generate results next year.
Food and Drug Administration (FDA) for the indication of diagnosing Electrographic Status Epilepticus (ESE). The clearance follows prior receipt of Breakthrough Device Designation from FDA. Subsequent to receiving Breakthrough Device Designation and 510(k) clearance from FDA, the U.S. per eligible Medicare patient case.
AccurKardia , a medical technology company delivering clinical-grade ECG interpretation software, announced today that its flagship product, the AccurECG Analysis System (“AccurECG” or the “System”), has been granted FDA 510(k) clearance. It is indicated for adults aged 22 and older.
Otsuka America Pharmaceutical and Lundbeck have received approval from the US Food and Drug Administration (FDA) for a new drug application for Abilify Asimtufii (aripiprazole) to treat schizophrenia or for maintenance monotherapy treatment of bipolar I disorder in adult patients.
The clock has started ticking on the FDA’s review of Sanofi and AstraZeneca’s one-shot antibody to protect newborns and infants from respiratory syncytial virus (RSV), with a decision due in the third quarter – just in time for the 2023/24 RSV season.
Welldoc ® , a digital health leader revolutionizing chronic care, today announced the receipt of its 10th 510(k) clearance from the Food and Drug Administration (FDA) for its award-winning diabetes digital health solution, BlueStar ®. This clearance reinforces Welldoc’s position as a leader in technology in diabetes management.
Food and Drug Administration (“FDA”) of BabySat , the first medical pulse-oximetry device featuring its advanced, wire-free sock design. Innovation in the baby care space matters because some of the largest issues facing caregivers and healthcareproviders have yet to be solved. BabySat will be available in the U.S.
In its 510(k) application to the FDA iHealthScreen has proposed the following indication for iPredict’s use: iPredict-AMD is indicated for use by health care providers to automatically detect more than early age-related macular degeneration (mteAMD) in adults above 50 years of age who have not been previously diagnosed with Late AMD (i.e.,
On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. And, if there are concerns, the pharmacist can call their healthcareprovider to develop a plan.
A pharmaceutical marketing company does more than run adsit builds connections between your brand, healthcareproviders (HCPs), and patients. The Value of an Expert Partner: Industry-Specific Expertise: Pharmaceutical marketing companies know the ins and outs of marketing drugs, from branded drug launches to FDA regulations.
Tom Ressemann: To diagnose ASD, healthcareproviders currently rely on subjective methods like parent questionnaires and behavioral observations of social interaction and communication skills, to identify autistic symptoms and restricted and repetitive patterns of behavior which define the condition. How is this suboptimal?
Meet the guest: Justin Ramsaran is an American digital health developer and entrepreneur who leverages cross-functional business strategies and digital transformation with artificial intelligence to empower individuals and advance healthcare systems.
It will provide a low-cost online consultation and prescription medicine service to patients, starting with the two oral COVID-19 antivirals – Pfizer’s Paxlovid (nirmatrelvir/ritonavir) and Merck & Co’s Lagevrio (molnupiravir) – which are authorised for at-home use by the FDA.
On 18 May 2023, the FDA announced the approval of Rinvoq (upadacitinib), AbbVie’s Janus kinase inhibitor (JAKi), to treat adults with moderately to severely active Crohn’s disease (CD) who have had an inadequate response or intolerance to one or more tumour necrosis factor (TNF) blockers.
Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch ® Ventricular Restoration System. This program is designed to ensure patients and healthcareproviders have more timely access to these medical devices. Ancora Heart , Inc., Press Release by: Ancora Heart. Are you hiring?
Applying AI to GVDs Amassing comprehensive productand market-related data, GVDs demonstrate the value of a pharmaceutical product to various stakeholders, including payers, healthcareproviders, and regulatory bodies. These tools also improve overall dossier quality by flagging inconsistencies, inaccuracies, or missing information.
ACTO LAICA RepAssist by ACTO is the first GenAI Knowledge Assistant built specifically for Life Sciences and is designed to improve healthcareprovider (HCP) interactions by providing pharma field reps with instant access to approved clinical and product information.
annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer. The post annalise.ai
Strategic Mergers and Acquisitions —Mergers and acquisitions (M&As) may offer strategic advantages to both Digital Health and DTx companies, providing access to complementary sales channels, expanding product offerings and customer base, and accelerating market penetration.
Clinical Knowledge: Possessing a basic understanding of relevant medical conditions and procedures related to your devices will enhance your interactions with healthcareproviders. Understanding relevant standards like FDA approvals demonstrates professionalism and ensures you promote your products ethically and compliantly.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content